Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#101 / 136 Total
WEST - Westrock Coffee Company - Stock Price Chart
TickerWEST [NASD, RUT]
CompanyWestrock Coffee Company
CountryUSA
IndustryPackaged Foods
Market Cap543.53MEPS (ttm)-0.54
P/E-EPS this Y-57.94%
Forward P/E34.14EPS next Y149.32%
PEG-EPS past 5Y-
P/S0.65EPS next 5Y-
P/B6.66EPS Q/Q43.30%
Dividend-Sales Q/Q-7.26%
Insider Own66.60%Inst Own31.31%
Insider Trans-0.53%Inst Trans-14.24%
Short Float20.20%EarningsAug 08/a
Analyst Recom1.00Target Price12.75
Avg Volume288.87K52W Range6.08 - 11.21
Westrock Coffee Co. engages in the production of coffee, tea, and extract products. The company was founded by Scott T. Ford and Joe T. Ford in 2009 and is headquartered in Little Rock, AR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FORD JOE TDirectorSep 12 '24Buy6.975,00034,850249,445Sep 12 05:15 PM
Umesiri OluwatoyinDirectorSep 10 '24Sale8.0711,50092,80514,240Sep 12 04:05 PM
Ford William AGROUP PRESIDENT, OPERATIONSSep 03 '24Buy7.781,0928,496436,190Sep 04 04:57 PM
FORD JOE TDirectorSep 03 '24Buy7.645,00038,200244,445Sep 04 04:43 PM
HF Direct Investments Pool, LL10% OwnerJul 31 '24Sale10.043,62936,43512,708,091Aug 02 04:05 PM
CBUS - Cibus Inc - Stock Price Chart
TickerCBUS [NASD, RUT]
CompanyCibus Inc
CountryUSA
IndustryBiotechnology
Market Cap79.84MEPS (ttm)-16.44
P/E-EPS this Y86.42%
Forward P/E-EPS next Y20.99%
PEG-EPS past 5Y10.61%
P/S26.97EPS next 5Y-
P/B0.26EPS Q/Q62.62%
Dividend-Sales Q/Q325.38%
Insider Own33.53%Inst Own31.69%
Insider Trans-0.07%Inst Trans-14.85%
Short Float13.87%EarningsAug 08/a
Analyst Recom1.50Target Price19.12
Avg Volume196.69K52W Range3.09 - 23.18
Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as Canola, Rice, Soybean, Corn and Wheat. The company was founded by Rory Riggs, Peter Beetham and Greg Gocal in 2010 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gocal Gregory Francis WilliamChief Scientific Officer & EVPJul 15 '24Sale10.012,00020,023314,844Jul 17 04:10 PM
Gocal Gregory Francis WilliamChief Scientific Officer & EVPJul 12 '24Sale10.002,00020,000316,844Jul 15 05:07 PM
Gocal Gregory Francis WilliamChief Scientific Officer & EVPJun 27 '24Sale10.002,00020,000318,844Jul 15 05:03 PM
RIGGS RORY BChief Executive OfficerDec 12 '23Buy10.58517,1075,470,9921,622,495Dec 14 05:10 PM
CHGG - Chegg Inc - Stock Price Chart
TickerCHGG [NYSE, RUT]
CompanyChegg Inc
CountryUSA
IndustryEducation & Training Services
Market Cap168.98MEPS (ttm)-6.30
P/E-EPS this Y-22.75%
Forward P/E1.65EPS next Y15.92%
PEG-EPS past 5Y-20.81%
P/S0.25EPS next 5Y15.00%
P/B0.46EPS Q/Q-5306.74%
Dividend-Sales Q/Q-10.78%
Insider Own4.98%Inst Own92.90%
Insider Trans0.00%Inst Trans-3.93%
Short Float13.27%EarningsAug 05/a
Analyst Recom3.29Target Price3.25
Avg Volume3.83M52W Range1.63 - 11.48
Chegg, Inc. engages in providing support and a learning platform for students. Its services include Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, Busuu offerings, Chegg Skills, advertising services, print textbooks, and eTextbooks offerings. The company was founded by Osman Rashid and Aayush Phumbhra on July 29, 2005 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schultz Nathan J.CHIEF OPERATING OFFICERDec 13 '23Sale10.411,35014,054421,025Dec 14 05:11 PM
Schultz Nathan J.CHIEF OPERATING OFFICERDec 04 '23Sale10.136306,382426,802Dec 05 01:35 PM
BROWN ANDREW JCHIEF FINANCIAL OFFICERNov 27 '23Sale10.0216,921169,54891,922Nov 29 07:52 PM
UONE - Urban One Inc - Stock Price Chart
TickerUONE [NASD]
CompanyUrban One Inc
CountryUSA
IndustryBroadcasting
Market Cap77.83MEPS (ttm)-2.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-57.27%
P/S0.17EPS next 5Y-
P/B0.33EPS Q/Q-167.40%
Dividend-Sales Q/Q-9.18%
Insider Own84.74%Inst Own6.56%
Insider Trans-0.49%Inst Trans-
Short Float0.54%Earnings-
Analyst Recom1.00Target Price6.00
Avg Volume55.80K52W Range1.63 - 6.05
Urban One, Inc. is a multi-media company, which engages in radio broadcasting that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, Cable Television, and All Other-Corporate and Eliminations. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the results of operations for the related activities and operations of the company's syndicated shows. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One and CLEO TV operations. The company was founded by Catherine L. Hughes in 1980 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson PeterCFO/EVPSep 23 '24Sale1.23200,000246,000320,642Sep 24 03:30 PM
KANTOR DAVID MCEO, Radio DivisionDec 28 '23Sale3.7587326273,527Jan 02 12:45 PM
SAGE - Sage Therapeutics Inc - Stock Price Chart
TickerSAGE [NASD, RUT]
CompanySage Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap426.74MEPS (ttm)-7.41
P/E-EPS this Y28.46%
Forward P/E-EPS next Y23.92%
PEG-EPS past 5Y-2.28%
P/S4.39EPS next 5Y16.80%
P/B0.68EPS Q/Q36.66%
Dividend-Sales Q/Q249.80%
Insider Own17.64%Inst Own88.67%
Insider Trans0.00%Inst Trans0.72%
Short Float11.58%EarningsJul 31/a
Analyst Recom2.84Target Price13.71
Avg Volume743.83K52W Range6.80 - 28.26
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
IGUCHI KIMICFO & TreasurerJan 02 '24Option Exercise1.361,6422,23370,429Jan 04 04:07 PM
FBRX - Forte Biosciences Inc - Stock Price Chart
TickerFBRX [NASD]
CompanyForte Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap7.30MEPS (ttm)-21.42
P/E-EPS this Y15.00%
Forward P/E-EPS next Y14.12%
PEG-EPS past 5Y51.36%
P/S-EPS next 5Y-
P/B0.43EPS Q/Q35.84%
Dividend-Sales Q/Q-
Insider Own10.99%Inst Own55.74%
Insider Trans0.00%Inst Trans-
Short Float0.26%EarningsAug 14/a
Analyst Recom1.00Target Price108.33
Avg Volume7.81K52W Range4.86 - 21.25
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riley Antony ACHIEF FINANCIAL OFFICEROct 01 '24Option Exercise0.0037508,395Oct 02 06:21 PM
Wagner Paul A.SEE REMARKSOct 01 '24Option Exercise0.001,250077,568Oct 02 06:19 PM
Riley Antony ACHIEF FINANCIAL OFFICERJul 01 '24Option Exercise0.009,3750203,849Jul 03 12:18 PM
Wagner Paul A.SEE REMARKSJul 01 '24Option Exercise0.0031,25001,910,424Jul 03 12:17 PM
Riley Antony ACHIEF FINANCIAL OFFICERApr 01 '24Option Exercise0.009,3750197,819Apr 02 06:32 PM
MGX - Metagenomi Inc. - Stock Price Chart
TickerMGX [NASD, RUT]
CompanyMetagenomi Inc.
CountryUSA
IndustryBiotechnology
Market Cap76.73MEPS (ttm)-2.52
P/E-EPS this Y85.26%
Forward P/E-EPS next Y1.82%
PEG-EPS past 5Y-
P/S1.37EPS next 5Y-
P/B0.29EPS Q/Q17.43%
Dividend-Sales Q/Q76.48%
Insider Own50.47%Inst Own25.91%
Insider Trans-0.03%Inst Trans-
Short Float1.08%EarningsAug 14/b
Analyst Recom1.29Target Price17.00
Avg Volume158.30K52W Range1.99 - 12.74
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wapnick PamelaChief Financial OfficerSep 05 '24Sale2.886,26518,04363,051Sep 06 05:14 PM
Novo Holdings A/S10% OwnerFeb 13 '24Buy15.00800,00012,000,0001,739,175Feb 15 08:38 PM
Novo Holdings A/S10% OwnerFeb 09 '24Buy10.25100,0001,025,000100,000Feb 15 08:38 PM
EDIT - Editas Medicine Inc - Stock Price Chart
TickerEDIT [NASD, RUT]
CompanyEditas Medicine Inc
CountryUSA
IndustryBiotechnology
Market Cap263.94MEPS (ttm)-2.36
P/E-EPS this Y-44.10%
Forward P/E-EPS next Y5.67%
PEG-EPS past 5Y2.88%
P/S3.94EPS next 5Y1.70%
P/B1.14EPS Q/Q-45.51%
Dividend-Sales Q/Q-82.23%
Insider Own0.94%Inst Own69.56%
Insider Trans-1.35%Inst Trans2.32%
Short Float23.21%EarningsAug 07/b
Analyst Recom2.05Target Price13.80
Avg Volume1.75M52W Range3.18 - 11.69
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mei BaisongEVP, CHIEF MEDICAL OFFICERSep 04 '24Sale3.425181,774133,895Sep 06 04:20 PM
O'Neill Gilmore NeilCEOSep 04 '24Sale3.421,5555,325313,724Sep 06 04:18 PM
O'Neill Gilmore NeilOfficerSep 03 '24Proposed Sale3.923,00011,760Aug 29 04:19 PM
Mei BaisongOfficerSep 03 '24Proposed Sale3.921,0003,920Aug 29 04:17 PM
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICERJul 25 '24Sale5.4211,88664,37073,136Jul 26 05:02 PM
SSTI - SoundThinking Inc - Stock Price Chart
TickerSSTI [NASD, RUT]
CompanySoundThinking Inc
CountryUSA
IndustrySoftware - Application
Market Cap153.62MEPS (ttm)-0.15
P/E-EPS this Y-65.91%
Forward P/E-EPS next Y40.64%
PEG-EPS past 5Y3.23%
P/S1.50EPS next 5Y20.00%
P/B2.03EPS Q/Q73.35%
Dividend-Sales Q/Q22.13%
Insider Own26.25%Inst Own57.27%
Insider Trans-0.53%Inst Trans6.53%
Short Float2.40%EarningsAug 06/a
Analyst Recom1.50Target Price24.07
Avg Volume62.00K52W Range10.88 - 26.92
SoundThinking, Inc. engages in providing precision-policing and security solutions. It also includes ShotSpotter, SecureCampus, and ShotSpotter SiteSecure solutions. The company was founded by Robert B. Calhoun, Jason Dunham, and Robert Leroy Showen in 1996 and is headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Golzadeh NasimSee remarksSep 10 '24Sale11.921661,97968,081Sep 18 08:15 PM
Clark Ralph A.President and CEOSep 03 '24Sale13.646,47988,360529,894Sep 05 06:34 PM
Golzadeh NasimSee remarksSep 03 '24Sale13.7574210,20168,247Sep 05 06:28 PM
Clark Ralph A.President and CEOAug 28 '24Sale14.365,59180,287536,373Aug 30 07:01 PM
Golzadeh NasimSee remarksAug 28 '24Sale14.083544,98668,989Aug 30 06:51 PM
IART - Integra Lifesciences Holdings Corp - Stock Price Chart
TickerIART [NASD, RUT]
CompanyIntegra Lifesciences Holdings Corp
CountryUSA
IndustryMedical Devices
Market Cap1.31BEPS (ttm)0.30
P/E57.44EPS this Y-20.99%
Forward P/E6.76EPS next Y2.32%
PEG9.12EPS past 5Y3.10%
P/S0.84EPS next 5Y6.30%
P/B0.86EPS Q/Q-410.47%
Dividend-Sales Q/Q9.68%
Insider Own16.14%Inst Own90.66%
Insider Trans0.71%Inst Trans1.30%
Short Float7.02%EarningsJul 29/b
Analyst Recom3.29Target Price27.30
Avg Volume1.14M52W Range16.96 - 45.42
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mosebrook JeffreySVP, Fin & Princ Acct OfficerAug 19 '24Sale21.581,19125,70136,088Aug 20 04:22 PM
ESSIG STUARTExec. Chairman of the BoardMay 23 '24Buy28.4952,6411,499,979487,922May 24 04:08 PM
HILL BARBARA BDirectorMay 21 '24Buy27.4036,350995,81636,350May 22 04:09 PM
De Witte JanPresident & CEOMar 11 '24Option Exercise0.00205018,555Mar 13 04:30 PM
De Witte JanPresident & CEOMar 10 '24Option Exercise0.00346018,696Mar 12 05:12 PM
167891011121314